T42 – Poisoning by, adverse effect of and underdosing of antiepileptic, sedative- hypnotic and antiparkinsonism drugs
Coding Notes
Active
Non-billable / Non-specific, not valid for HIPAA-covered transactions
Tyoe 2 Excludes
drug dependence and related mental and behavioral disorders due to psychoactive substance use (F10.--F19.-)
Child Codes
Sibling Codes
View in Tabular
Code | Title |
---|---|
S00-T88 | Injury, poisoning and certain other consequences of external causes (S00-T88) |
T36-T50 | Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50) |
T42 |
Poisoning by, adverse effect of and underdosing of antiepileptic, sedative- hypnotic and antiparkinsonism drugs
Type 2 Excludes
drug dependence and related mental and behavioral disorders due to psychoactive substance use (F10.--F19.-)
|
T42.0 | Poisoning by, adverse effect of and underdosing of hydantoin derivatives |
T42.0X | Poisoning by, adverse effect of and underdosing of hydantoin derivatives |
T42.0X1 | Poisoning by hydantoin derivatives, accidental (unintentional) |
T42.0X2 | Poisoning by hydantoin derivatives, intentional self-harm |
T42.0X3 | Poisoning by hydantoin derivatives, assault |
T42.0X4 | Poisoning by hydantoin derivatives, undetermined |
T42.0X5 | Adverse effect of hydantoin derivatives |
T42.0X6 | Underdosing of hydantoin derivatives |
T42.1 | Poisoning by, adverse effect of and underdosing of iminostilbenes |
T42.1X | Poisoning by, adverse effect of and underdosing of iminostilbenes |
T42.1X1 | Poisoning by iminostilbenes, accidental (unintentional) |
T42.1X2 | Poisoning by iminostilbenes, intentional self-harm |
T42.1X3 | Poisoning by iminostilbenes, assault |
T42.1X4 | Poisoning by iminostilbenes, undetermined |
T42.1X5 | Adverse effect of iminostilbenes |
T42.1X6 | Underdosing of iminostilbenes |
T42.2 | Poisoning by, adverse effect of and underdosing of succinimides and oxazolidinediones |
T42.2X | Poisoning by, adverse effect of and underdosing of succinimides and oxazolidinediones |
T42.2X1 | Poisoning by succinimides and oxazolidinediones, accidental (unintentional) |
T42.2X2 | Poisoning by succinimides and oxazolidinediones, intentional self-harm |
T42.2X3 | Poisoning by succinimides and oxazolidinediones, assault |
T42.2X4 | Poisoning by succinimides and oxazolidinediones, undetermined |
T42.2X5 | Adverse effect of succinimides and oxazolidinediones |
T42.2X6 | Underdosing of succinimides and oxazolidinediones |
T42.3 | Poisoning by, adverse effect of and underdosing of barbiturates |
T42.3X | Poisoning by, adverse effect of and underdosing of barbiturates |
T42.3X1 | Poisoning by barbiturates, accidental (unintentional) |
T42.3X2 | Poisoning by barbiturates, intentional self-harm |
T42.3X3 | Poisoning by barbiturates, assault |
T42.3X4 | Poisoning by barbiturates, undetermined |
T42.3X5 | Adverse effect of barbiturates |
T42.3X6 | Underdosing of barbiturates |
T42.4 | Poisoning by, adverse effect of and underdosing of benzodiazepines |
T42.4X | Poisoning by, adverse effect of and underdosing of benzodiazepines |
T42.4X1 | Poisoning by benzodiazepines, accidental (unintentional) |
T42.4X2 | Poisoning by benzodiazepines, intentional self-harm |
T42.4X3 | Poisoning by benzodiazepines, assault |
T42.4X4 | Poisoning by benzodiazepines, undetermined |
T42.4X5 | Adverse effect of benzodiazepines |
T42.4X6 | Underdosing of benzodiazepines |
T42.5 | Poisoning by, adverse effect of and underdosing of mixed antiepileptics |
T42.5X | Poisoning by, adverse effect of and underdosing of antiepileptics |
T42.5X1 | Poisoning by mixed antiepileptics, accidental (unintentional) |
T42.5X2 | Poisoning by mixed antiepileptics, intentional self-harm |
T42.5X3 | Poisoning by mixed antiepileptics, assault |
T42.5X4 | Poisoning by mixed antiepileptics, undetermined |
T42.5X5 | Adverse effect of mixed antiepileptics |
T42.5X6 | Underdosing of mixed antiepileptics |
T42.6 | Poisoning by, adverse effect of and underdosing of other antiepileptic and sedative-hypnotic drugs |
T42.6X | Poisoning by, adverse effect of and underdosing of other antiepileptic and sedative-hypnotic drugs |
T42.6X1 | Poisoning by other antiepileptic and sedative-hypnotic drugs, accidental (unintentional) |
T42.6X2 | Poisoning by other antiepileptic and sedative-hypnotic drugs, intentional self-harm |
T42.6X3 | Poisoning by other antiepileptic and sedative-hypnotic drugs, assault |
T42.6X4 | Poisoning by other antiepileptic and sedative-hypnotic drugs, undetermined |
T42.6X5 | Adverse effect of other antiepileptic and sedative-hypnotic drugs |
T42.6X6 | Underdosing of other antiepileptic and sedative-hypnotic drugs |
T42.7 | Poisoning by, adverse effect of and underdosing of unspecified antiepileptic and sedative-hypnotic drugs |
T42.71 | Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, accidental (unintentional) |
T42.72 | Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, intentional self-harm |
T42.73 | Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, assault |
T42.74 | Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, undetermined |
T42.75 | Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs |
T42.76 | Underdosing of unspecified antiepileptic and sedative-hypnotic drugs |
T42.8 | Poisoning by, adverse effect of and underdosing of antiparkinsonism drugs and other central muscle-tone depressants |
T42.8X | Poisoning by, adverse effect of and underdosing of antiparkinsonism drugs and other central muscle-tone depressants |
T42.8X1 | Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, accidental (unintentional) |
T42.8X2 | Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, intentional self-harm |
T42.8X3 | Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, assault |
T42.8X4 | Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, undetermined |
T42.8X5 | Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants |
T42.8X6 | Underdosing of antiparkinsonism drugs and other central muscle-tone depressants |